Economic assessment of three antimicrobial therapies for uncomplicated urinary tract infection in women

Clinical Therapeutics

Volumn 21, Issue 9, 1999, Pages 1578-1588

  Huang, Xingyue ^a,b   Hartzema, Abraham G ^a   Raasch, Ralph H ^a   Kauf, Teresa L ^a   Norwood, G Joseph ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b NONE   (United States)

Author keywords

Antimicrobial therapies; Ciprofloxacin; Cohort study; Economic assessment; Medicaid; Nitrofurantoin; Trimethoprim sulfamethoxazole; Urinary tract infection

Indexed keywords

CIPROFLOXACIN; COTRIMOXAZOLE; NITROFURANTOIN;

ADOLESCENT; ADULT; ANTIMICROBIAL THERAPY; ARTICLE; COST EFFECTIVENESS ANALYSIS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; REIMBURSEMENT; RETROSPECTIVE STUDY; TREATMENT OUTCOME; URINARY TRACT INFECTION;

EID: 0032820210     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(00)80012-0     Document Type: Article

References (28)

1. Johnson CC. Definitions, classification, and clinical presentation of urinary tract infections. Med Clin North Am. 1991;75:241-252.
2. Powers RD. New directions in the diagnosis and therapy of urinary tract infections. Am J Obstet Gynecol 1991;164:1387-1389.
3. Stamm WE, Hooton TM. Management of urinary tract infections in adults. N Engl J Med. 1993;329:1328-1334.
4. Patton JP, Nash DB, Abrutyn E. Urinary tract infection: Economic considerations. Med Clin North Am. 1991;75:495-513.
5. Woodwell DA. Office visits to urologists: United States, 1989-1990. Advance Data from Vital and Health Statistics, no. 234. Hyattsville, Md: National Center for Health Statistics; 1995:8.
6. Thomson KS, Sanders WE, Sanders CC. USA resistance patterns among UTI pathogens. J Antimicrob Chemother. 1994; 33(Suppl A):9-15.
7. Grüneberg RN. Changes in urinary pathogens and their antimicrobial sensitivities, 1971-1992. J Antimicrob Chemother. 1994;33(Suppl A):1-8.
8. Ansbach RK, Dybus KR, Bergeson R. Uncomplicated E coli urinary tract infection in college women: A retrospective study of E coli sensitivities to commonly prescribed antibiotics. J Am Coll Health. 1995;43:183-185.
9. Carlson KJ, Mulley AG. Management of acute dysuria. A decision-analysis model of alternative strategies. Ann Intern Med. 1985;102:244-249.
10. Hooton TM, Winter C, Tiu F, Stamm WE. Randomized comparative trial and cost analysis of 3-day antimicrobial regimens for treatment of acute cystitis in women. JAMA. 1995;273:41-45.
11. International Classification of Diseases, Ninth Revision. Clinical Modification. Hyattsville, Md: US Department of Health and Human Services, Public Health Service; 1998:135.
12. Boyko EJ, Iravani A, Silverman MH, et al. Randomized, controlled trial of a 10-day course of amifloxacin versus trimethoprim-sulfamethoxazole in the treatment of acute, uncomplicated urinary tract infection. Amifloxacin Multi-Center Trial Group. Antimicrob Agents Chemother. 1990;34:665-667.
13. Henry NK, Schultz HJ, Grubbs NC, et al. Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women. J Antimicrob Chemother. 1986;18(Suppl D):103-106.
14. Iravani A, Richard GA, Baer H. Trimethoprim once daily vs. nitrofurantoin in treatment of acute urinary tract infections in young women, with special reference to periurethral, vaginal, and fecal flora. Rev Infect Dis. 1982;4:378-386.
15. Iravani A, Tice AD, McCarty J, et al. Short-course ciprofloxacin treatment of acute uncomplicated urinary tract infection in women. The minimum effective dose. The Urinary Tract Infection Study Group. Arch Intern Med. 1995;155:485-494.
16. Iravani A. Multicenter study of single-dose and multiple-dose fleroxacin versus ciprofloxacin in the treatment of uncomplicated urinary tract infections. Am J Med. 1993;94(Suppl 3A):89S-96S.
17. Lightstone BL, Greaves WE, Humphries JM. Comparison of Mictral with amoxycillin, trimethoprim and nitrofurantoin in the treatment of acute cystitis. Br J Clin Pract. 1988;42:283-288.
18. Masterton RG, Bochsler JA. High-dosage co-amoxiclav in a single dose versus 7 days of co-trimoxazole as treatment of uncomplicated lower urinary tract infection in women. J Antimicrob Chemother. 1995;35:129-137.
19. Naber KG, Thyroff-Friesinger U. Fosfomycin trometamol versus ofloxacin/co-trimoxazole as single dose therapy of acute uncomplicated urinary tract infection in females: A multicentre study. Infection. 1990;18(Suppl 2):S70-S76.
20. Pfau A, Sacks TG. Single dose quinolone treatment in acute uncomplicated urinary tract infection in women. J Urol. 1993;149:532-534.
21. Reid G, Bruce AW, Taylor M. Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections. Clin Ther. 1992;14:11-16.
22. Spencer RC, Moseley DJ, Greensmith MJ. Nitrofurantoin modified release versus trimethoprim or co-trimoxazole in the treatment of uncomplicated urinary tract infection in general practice. J Antimicrob Chemother. 1994;33(Suppl A): 121-129.
23. Stein GE, Philip E. Comparison of three-day temafloxacin with seven-day ciprofloxacin treatment of urinary tract infections in women. J Fam Pract. 1992;34:180-184.
24. Trienekens TAM, Stobberingh EE, Winkens RAG, Houben AW. Different lengths of treatment with co-trimoxazole for acute uncomplicated urinary tract infections in women. Br Med J. 1989;299:1319-1322.
25. Physicians' Desk Reference®. 50th ed. Montvale, NJ: Medical Economics Company; 1996:593, 1989, 2086.
26. USPDI 18th Edition. Rockville, Md: US Pharmacopeial Convention; 1996.
27. Drug Facts and Comparisons. St. Louis, Mo: Facts and Comparisons; 1994:340k-340i, 432, 409a-409b.
28. Mockenhaupt M, Schopf E. Epidemiology of drug-induced severe skin reactions. Sem Cutaneous Med Surg. 1996;15:236-243.